Insights

Strategic expansion Nusano is rapidly expanding its West Valley City and Salt Lake City facilities with multi-hundred-million dollar investments, signaling growing demand for radiopharmaceuticals and industrial isotopes. This presents sales opportunities for component suppliers, facility construction, regulatory consultants, and uptime optimization solutions to support scalable production.

Supply stability imperative The company emphasizes reliable access to high-quality radioisotopes to prevent treatment delays and support critical applications. This creates a sales angle for inventory management systems, demand forecasting, and fast-response logistics partnerships to ensure steady supply chains for healthcare providers and manufacturers.

Healthcare & space Nusano targets applications from cancer treatment to space exploration and energy, indicating diverse customer segments including hospitals, radiopharmacies, and aerospace/energy firms. There are cross-selling opportunities for specialized imaging agents, regulatory-compliant sourcing, and tailored support services across these sectors.

Industry recognition Awards for innovation and being named among best companies to work for enhance credibility with potential customers and partners. Leverage this in outreach campaigns to establish trust, while offering a consultative onboarding or pilot programs to convert interest into contracts.

Talent and partnerships Leadership recognition and a growing team, including a noted logistics director, point to mature operations and partner-ready capabilities. Target partnerships in logistics, compliance, training, and customer service outsourcing to strengthen Nusano’s end-to-end value proposition.

Similar companies to Nusano

Nusano Tech Stack

Nusano uses 8 technology products and services including Google Ads, Grafana, Kubernetes, and more. Explore Nusano's tech stack below.

Media & News

Nusano's Email Address Formats

Nusano uses at least 3 email formats:
Nusano Email FormatsExamplePercentage
First.Last@nusano.comJohn.Doe@nusano.com
98%
First.Middle@nusano.comJohn.Michael@nusano.com
1%
First@nusano.comJohn@nusano.com
1%

Frequently Asked Questions

What is Nusano's official website and social media links?

Minus sign iconPlus sign icon
Nusano's official website is nusano.com and has social profiles on LinkedIn and Crunchbase.

How much revenue does Nusano generate?

Minus sign iconPlus sign icon
As of July 2026, Nusano's annual revenue is estimated to be $50M - $100M.

What is Nusano's SIC code and NAICS code?

Minus sign iconPlus sign icon
Nusano's SIC code is 8731 - Commercial Physical and Biological Research and NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Nusano have currently?

Minus sign iconPlus sign icon
As of July 2026, Nusano has approximately 173 employees across 1 continents, including North America. Key team members include Chief Executive Officer: N. W., Senior Accelerator Mechanical Engineer: J. W. and Customer Service Staff: C. B. Explore Nusano's employee directory with LeadIQ.

What industry does Nusano belong to?

Minus sign iconPlus sign icon
Nusano operates in the Biotechnology Research industry.

What technology does Nusano use?

Minus sign iconPlus sign icon
Nusano's tech stack includes Google Ads, Grafana, Kubernetes, GitLab CI, MongoDB, Microsoft Dynamics, ADP and Vimeo.

What is Nusano's email format?

Minus sign iconPlus sign icon
Nusano's email format typically follows the pattern of First.Last@nusano.com. Find more Nusano email formats with LeadIQ.

How much funding has Nusano raised to date?

Minus sign iconPlus sign icon
As of July 2026, Nusano has raised $115M in funding. The last funding round occurred on Oct 01, 2024 for $115M.
Nusano logo

Nusano

Biotechnology ResearchUtah, United States51-200 Employees

Nusano is a biotechnology research company focused on producing both medical and industrial radioisotopes. Its work supports critical applications in cancer treatment, space exploration, reducing nuclear waste, and enabling advances in alternative energy. The company operates a facility in West Valley City, Utah, designed to produce isotopes efficiently and sustainably using its proprietary ion source technology. It seeks to be a dependable supplier within the radiopharmaceutical and broader isotope supply chain, meeting the needs of customers in healthcare and industry.

Its customers include healthcare providers and industrial users who rely on consistent access to radioisotopes for diagnostics, treatment, and research, with an emphasis on supply stability. In May 2026, Nusano announced an expansion to Salt Lake City to establish a larger isotope facility that will supply starting materials for next-generation radiopharmaceuticals.

Section iconCompany Overview

Website
nusano.com
SIC Code
8731 - Commercial Physical and Biological Research
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Employees
51-200

Section iconFunding & Financials

  • $115M

    Nusano has raised a total of $115M of funding over 2 rounds. Their latest funding round was raised on Oct 01, 2024 in the amount of $115M as a Series C.

  • $50M - $100M

    Nusano's revenue is estimated to be in the range of $50M - $100M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.